Investors back INTEGA's buy of Valeant Groupe Cosméderme
INTEGA Skin Sciences Inc, a Montréal-based dermatology specialist, has agreed to buy Valeant Groupe Cosméderme from the Canadian division of Valeant Pharmaceuticals International Inc. No financial terms were disclosed for the deal, which includes three high-end medical skincare brands developed and manufactured in Laval, Québec. Founded last year by President and CEO Gregory Orleski, INTEGA was backed in the acquisition by Knight Therapeutics Inc and Bloom Burton Healthcare Lending Trust. It said it "aspires to become the Canadian benchmark in the pharmaceutical industry for the treatment and care of skin diseases."
25 January 2016•5 mins read
